Phase Ib, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety of RO7486967 in Patients With Chronic Obstructive Pulmonary Disease
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: F. HOFFMANN-LA ROCHE LTD
- Phase: I
- Execution start: 20/01/2022
- End of execution: 30/12/2022
- PI: BERNARDINO ALCAZAR NAVARRETE